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infection in a Jack Russell 
terrier
AbstRACt
A twenty-month-old Jack Russell terrier was presented with a four-day history of thrombocytopenia, echymotic inguinal haemorrhages, 
coughing and reduced exercise tolerance. Clinical examination revealed several petechial haemorrhages on the gingivae and small 
echymotic haemorrhages in the inguinal region, along with mild bilateral epistaxis. Haematology confirmed a platelet count of 1.0 x 
10/L. Thoracic radiographs revealed a wide-spread mixed alveolar-interstitial lung pattern, apparent throughout the entire lungfield, 
but particularly marked within the left lung lobes. A presumptive diagnosis of immune-mediated thrombocytopenia was made and the 
dog was treated with vincristine and immunosuppressive doses of prednisolone. Initially anaemia developed following gastrointestinal 
haemorrhage; however, after symptomatic treatment the dog showed a marked clinical improvement. Evaluation for an underlying cause 
of the disease revealed Angiostrongylus vasorum L1 larvae on faecal analysis and treatment with fenbendazole was commenced. The 
dog made a full clinical recovery with all treatment was withdrawn within five weeks of diagnosis. This is the second report of immune-
mediated thrombocytopenia associated with Angiostrongylus vasorum infection and it is the first to be successfully managed. The report 
highlights that Angiostrongylus vasorum should be considered in young dogs presented with thrombocytopenia.
KeyWoRDs: Lung worm, dog, platelets Irish Veterinary Journal
Volume 63 Number 6 2010
INtRoDUCtIoN
Thrombocytopenia is the most commonly occurring 
platelet disorder in dogs (Feldman et al., 1988), 
with a prevalence rate among the admissions to one 
US hospital of approximately 5% (Grindem et al., 
1991). Thrombocytopenia may result from a variety of 
pathophysiological mechanisms including reduced platelet 
production, increased platelet sequestration, increased 
platelet utilisation or destruction (Davenport et al., 1982).  
Immune-mediated thrombocytopenia (IMTP) is a disease 
characterised by the premature destruction of antibody-
coated platelets by macrophages (Lewis and Meyers, 
1996). This disease may occur as a primary disease, 
termed primary IMTP or idiopathic thrombocytopenic 
purpura, or as a secondary disease associated with 
conditions such as neoplasia, inflammation or infection 
(Lewis and Meyers, 1996). The pathogenesis of primary 
IMTP is thought to involve the production of antibodies 














Irish Veterinary Journal Volume 63 Number 7 435
directed against normal host platelet-surface antigens, 
whereas in secondary IMTP the pathogenesis remains 
largely undefined (Lewis and Meyers, 1996). 
Angiostrongylus vasorum is a metastrongyloid nematode 
that parasitises dogs and other Canidae via an indirect 
lifecycle involving slugs, snails and frogs that act as 
intermediate or paratenic hosts (Bolt et al., 1994; Rosen 
et al., 1970). This life cycle has been extensively reviewed 
elsewhere (Rosen et al., 1970; Bolt et al., 1994).  The first 
report of Angiostrongylus vasorum infection in Ireland was 
in a Greyhound (Roche and Kelliher, 1968). Following this, 
the infection became well-recognised within Greyhound 
kennels in Ireland (Dodd, 1973) and the first reported 
case in England was a Greyhound that had been imported 
from Ireland (Jacobs and Prole, 1975). More recently, 
Angiostrongylus vasorum infection has been reported 
in several pet dogs in Ireland (Brennan et al., 2004); 
however, the overall prevalence of the nematode in this 
country is unknown (Brennan et al., 2004).
A wide variety of clinical signs have been associated with 
Angiostrongylus vasorum infection. Commonly reported 
clinical signs include cardiopulmonary signs such as 
coughing, exercise intolerance and dyspnoea (Prestwood 
et al., 1981; Martin et al., 1993; Patteson et al., 1993).  
In some cases progression of the signs to right-sided 
heart failure (Guelfi, 1976) or sudden death attributed to 
acute heart failure (King et al., 1994) has been reported.  
Coagulopathies have also been widely reported in 
association with both naturally occurring and experimental 
Angiostrongylus vasorum infections (Dodd, 1973; Schelling 
et al., 1986; Simpson et al., 1996; Brennan et al., 
2004; Chapman et al., 2004).  In addition, neurological 
and ocular signs have been documented (Garosi et al., 
2005; Wessmann et al., 2006; Manning, 2007) or more 
general signs such as weight loss, poor growth and 
weakness (Dodd, 1973).  Asymptomatic infections have 
been observed in some individuals (Martin et al., 1993; 
Patteson et al., 1993).
Thrombocytopenia has been reported in association with 
Angiostrongylus vasorum infection in a number of canine 
cases (Schelling et al., 1986; Patteson et al., 1993; 
Ramsey et al., 1996; Gould and McInnes 1999; Cury et 
al., 2002; Brennan et al., 2004; Chapman et al., 2004; 
Willesen et al., 2009) with reported incidences in the two 
largest case series of four out of 20 cases (Chapman 
et al., 2004) and two out of 35 cases (Willesen et al., 
2009). In one of the previous cases, the cause of the 
thrombocytopenia was demonstrated to be immune-
mediated (Gould and McInnes, 1999).  In other cases the 
cause has been attributed to a consumptive coagulopathy 
resembling disseminated intravascular coagulation 
(Schelling et al., 1986; Ramsey et al., 1996; Cury et al., 
2002). 
This case report describes the presentation, diagnosis 
and successful treatment of a Jack Russell Terrier with 
severe immune-mediated thrombocytopenia associated 
with Angiostrongylus vasorum infection. To the authors’ 
knowledge, this is only the second report of IMTP and 
Angiostrongylus vasorum infection and is the first to be 
diagnosed antemortem.
CAse HIstoRy
A twenty-month-old male entire Jack Russell Terrier was 
presented to the University Veterinary Hospital (UVH), 
University College Dublin with a four-day history of 
thrombocytopenia, small inguinal echymotic haemorrhages, 
coughing and reduced exercise tolerance.
The dog had shown sudden onset coughing and retching 
that had commenced at exercise. The referring veterinarian 
had performed bronchoscopy on day one, which had 
revealed a stream of blood running ventrally along the 
trachea, appearing to source from the right main-stem 
bronchus. The bronchoscopy had been terminated 
at this stage and further examination had revealed 
small echymotic haemorrhages in the inguinal region.  
Treatment with Vitamin K1 (Konakion; Roche) at a dose 
of 10 mg twice daily per os had been commenced and 
a blood sample submitted to the UVH clinical pathology 
laboratory for haematology and a coagulation screen.  
The haematology results were received on day three 
and revealed severe thrombocytopenia (2.0 x 109/L), 
evidence of increased erythrocyte turnover but without 
anaemia (packed cell volume (PCV) 0.38 L/L), a mature 
neutrophilia (16.8 x 109/L) and a monocytosis (2.6 x 
109/L).  There was no known access to rodenticides and 
the dog had not received drug therapy other than vitamin 
K1.The coagulation screen gave results within the normal 
reference ranges. The dog was referred on day four.
At initial presentation the dog was bright, alert and in 
good body condition (weight 7.3 kg). Only very occasional 
coughing had been observed since first presentation, 
although exercise intolerance was apparent. A clinical 
examination revealed pink mucous membranes with 
a normal capillary refill time. The respiratory rate was 
approximately 36 breaths per minute with a slight 
increase in lung sounds noted bilaterally on auscultation. 
There were several petechial haemorrhages evident on 
the gingivae, along with mild bilateral epistaxis and the 
inguinal echymoses.  
Haematology at the time of referral (day four) 
demonstrated severe thrombocytopenia (1.0 x 109/L 
machine count, confirmed as accurate on examination of 
a smear) accompanied by a mild, regenerative anaemia 
(PCV 0.27 L/L).  Serum biochemistry demonstrated mild 
hyperglobulinaemia (45.7 g/L) and mild elevation of serum 
alkaline phosphatase (103 U/L). Thoracic radiography 
(Figure 1) revealed a widespread mixed alveolar-interstitial 
lung pattern. This was apparent throughout the lungfield, 
but was particularly marked within the left lung lobes, 
which contained subtle air bronchograms. Pleural fissure 
lines were visible between both the right middle and right 
caudal lobes and the accessory and left caudal lung lobes, 
however a significant pleural effusion was not discernable.  
Right lateral and dorso-ventral abdominal radiographs 
demonstrated no significant abnormalities. 
A presumptive diagnosis of immune-mediated 
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thrombocytopenia was made and treatment was 
commenced on day four with vincristine (Vincristine; 
Faulding Pharmaceuticals Ltd.) at a single dose of 0.02 
mg/kg i/v and prednisolone (Prednicare; Animalcare) 
at a dose of 2.7 mg/kg split twice daily per os (10 mg 
twice daily). The dog was confined to strict cage rest with 
minimal handling to minimise the risk of spontaneous 
haemorrhage. 
Over the next three days of hospitalization coughing or 
changes in respiratory rate were not observed. Several 
small echymotic haemorrhages developed on the ventral 
abdomen on day two of hospitalisation (day six) but other 
signs were not observed, although his appetite was poor.  
Haematology was performed daily to monitor the PCV and 
platelet count. Significant change in the platelet count was 
not observed over the first three days of treatment.  
On the fourth day of hospitalisation (day seven), the PCV 
had dropped to 0.19 L/L despite the absence of evidence 
of further bleeding on clinical examination. Spherocytes 
were not noted on the blood smear and a Coombs’ test 
was negative. At this stage, gastrointestinal blood loss was 
a concern and treatment was commenced with ranitidine 
(Zantac; GlaxoWellcome) at a dose of 2 mg/kg every eight 
hours and sucralfate (Antepsin; Chugai) at a dose of 400 
mg every eight hours. The dog had passed no faeces since 
its admission. No rectal examination was performed. In 
view of the sudden decline in PCV, major and minor cross 
matches were performed against two blood donors in 
case of a requirement for a blood transfusion should the 
dog deteriorate further. Severe thrombocytopenia (6.0 x 
109/L) was still apparent following an automated platelet 
count, however manual counts revealed approximately five 
platelets per high power field, suggesting higher numbers 
were present and some platelet clumping was occurring.
Faeces passed at the end of day seven, showed evidence 
of both melaena and haematochezia. Samples were 
submitted for a modified Baermann examination to 
evaluate for lungworm larvae (Urquhart et al., 1996).  
Angiostrongylus vasorum L1 larvae were identified in the 
faecal sample confirming a patent infection with the 
parasite. These results were received on day seven of 
hospitalisation (day 10).  Treatment was commenced with 
fenbendazole (Panacur; Hoechst) at a dose of 50 mg/
kg daily for seven days in addition to the prednisolone, 
ranitidine and sucralfate. The dog continued to be bright 
over the next four days and showed no clinical evidence of 
haemorrhage or melaena. On day eleven of hospitalisation 
(day 14 of the history), the platelet count had risen to 
24.0 x 109/L, although examination of the smear again 
identified platelet clumping suggesting the true count was 
considerably higher. A buccal mucosal bleeding time was 
performed to confirm adequate primary haemostasis; a 
normal result was obtained and the dog was discharged.  
Ranitidine and sucralfate treatment was discontinued.  The 
prednisolone was continued at a dose of 1.4 mg/kg (10 
mg) per os daily and the seven-day course of fenbendazole 
completed. After two weeks the prednisolone was reduced 
to 0.7 mg/kg (5mg) per os daily. 
The dog was re-examined at the UVH three weeks after the 
initial referral.  At this stage residual clinical signs were not 
apparent and the platelet count was within the reference 
range. Lungworm larvae were not observed on faecal 
examination.  The prednisolone dose was reduced to 0.7 
mg/kg (5mg) per os every 48 hours for one week and then 
0.35 mg/kg (2.5 mg) every 48 hours for a further week 
before being completely withdrawn. The dog has had no 
recurrence of clinical signs for seventeen months.  
Figure 1 Right lateral (A) and dorsoventral (B) thoracic 
radiographs taken on the day of referral (day four), showing 
a widespread mixed alveolar-interstitial lung pattern.  This 
is visible throughout the lungfield, but is particularly 
marked within the left lung lobes .  Pleural fissure lines are 
visible between both the right middle and right caudal lobes 
and the accessory and left caudal lung lobes, however a 
significant pleural effusion is not discernable.  
(A)
(B)
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DIsCUssIoN
Thrombocytopenia may result from reduced platelet 
production, increased platelet sequestration, increased 
platelet utilisation or destruction (Davenport et al., 
1982).  Consumptive coagulopathies represent the most 
common cause of increased platelet utilisation, whereas 
immune-mediated thrombocytopenia, either primary or 
secondary, is the most common cause of increased 
platelet destruction (Davenport et al., 1982).  IMTP may 
occur in association with other immunological diseases 
such as systemic lupus erythematosus (Joshi and Jain, 
1977) or secondary to other conditions such as neoplasia, 
inflammation and infection (Davenport et al., 1982) or 
following drug administration (Trepanier et al., 2003). In 
dogs, the infectious processes that have been reported 
in association with thrombocytopenia include; bacterial 
infections, rickettsial infections and parasitic infections 
(Breitschwerdt, 1988) including both dirofilariasis (Grindem 
et al., 1991) and angiostrongylosis (Gould and McInnes, 
1999). These infectious agents have the potential to induce 
autoimmunity via a variety of immunological mechanisms, 
for example molecular mimicry or the induction or alteration 
of host antigens (Day, 1999).  However, the potential role 
that these or other immunological processes might play in 
canine secondary, infection-related IMPT cases remains 
largely undefined. 
A variety of criteria have been used to confirm a diagnosis 
of canine primary IMTP, including; the severity of 
thrombocytopenia, the presence of microthrombocytosis 
or platelet fragmentation, detection of anti-platelet 
autoantibodies, increased platelet counts following 
the administration of immunosuppressive doses of 
corticosteroids, normal to increased numbers of 
megakaryocytes in bone marrow and the exclusion of other 
aetiologies of thrombocytopenia (Lewis and Meyers, 1996).  
It is widely accepted that there is no “gold standard” for 
diagnosis (Day and Mackin, 1999). Firstly, whilst a positive 
test result for either platelet-bound or serum platelet-
bindable IgG in a dog with thrombocytopenia implies an 
immune pathogenesis, it does not aid differentiation 
between primary and secondary IMTP (Lewis and Meyers, 
1996).  Secondly, whilst direct assays for surface-bound 
antibodies in IMTP offer high sensitivity compared to that 
achieved by indirect assays detecting serum antibodies 
(Lewis et al., 1995), these direct assays can be difficult to 
perform in cases with very severe thrombocytopenia due 
to insufficient platelet numbers (Day and Mackin, 1999).  
Performing a megakaryocyte direct immunofluorescence 
assay may alleviate the latter problem, however the 
reported sensitivity with this test is highly variable (30% 
to 80%) (Joshi and Jain, 1976; Jackson and Kruth, 1985; 
Kristensen et al., 1994b).  Hence, this test has the 
potential to generate significant numbers of false negative 
results and has the additional disadvantage of requiring 
a bone marrow aspirate.  More recently platelet-bound 
antibodies have been evaluated by flow cytometric assay 
alleviating the problems associated with low platelet 
numbers (Dircks et al., 2009), however this technique still 
does not allow the differentiation between primary and 
secondary IMTP.
In view of the limitations of the immunological testing 
outlined above and the limited availability of anti-platelet 
antibody tests, a presumptive diagnosis of IMTP was 
made in the current case. This diagnosis was based on 
the initial severity of the thrombocytopenia, the response 
to immunosuppressive corticosteroid therapy and the 
exclusion of a consumptive coagulopathy. The initial 
severity of the thrombocytopenia has been suggested to 
be a reliable feature of IMPT cases (Grindem et al., 1991; 
Lewis et al., 1995). A response to corticosteroid therapy 
provides evidence of an immune-mediated pathogenesis 
(Lewis et al., 1995); typically IMTP cases will have platelet 
counts of greater than 50 to 100 x 109/L within seven 
days of initiating treatment (Lewis et al., 1995). There 
is no definitive laboratory test to confirm a diagnosis of 
disseminated intravascular coagulation (DIC); however, low 
platelet counts, erythrocyte fragmentation on peripheral 
blood smears, prolonged clotting times, low levels of 
antithrombin, and high levels of fibrin degradation products 
are accepted to be helpful indicators (Feldman et al., 1981; 
Slappendel, 1988). In this dog there was no evidence 
of erythrocyte fragmentation and no prolongation of the 
clotting times.  In addition, the thrombocytopenia was 
more marked than would typically be associated with DIC; 
thrombocytopenia at this level being much more typical 
of IMTP (Grindem et al., 1991). Ideally, measurement of 
fibrin degradation products or d-dimers would have provided 
further evaluation for DIC. However the FDP assay was 
not performed due to a lack of reagents when a sample 
was submitted (day four) to an external laboratory, and 
unfortunately the sample was not retained. A d-dimer 
assay was not available at the time. Despite this, in view 
of the lack of other suggestive signs and the response 
to treatment, the diagnosis of DIC was considered highly 
unlikely.
The majority of reported cases of angiostrongylosis have 
occurred in young dogs (Martin et al., 1993; Patteson et 
al., 1993), as in this case. A wide variety of clinical signs 
have been associated with infection, with respiratory signs, 
such as coughing, widely accepted as one of the most 
common clinical signs (Prestwood et al., 1981; Martin et 
al., 1993; Patteson et al., 1993; Chapman et al., 2004), 
as was observed in this current case. Clinical signs relating 
to a haemorrhagic diathesis are also common, reported to 
occur in approximately one third of the cases (Chapman et 
al., 2004). Subcutaneous, mucosal and internal bleeding 
have all been reported (Brennan et al., 2004; Chapman 
et al., 2004), including haemorrhage within the central 
nervous system (Garosi et al., 2005). The mechanism 
underlying this bleeding tendency remains poorly 
characterized; various mechanisms have been proposed 
including chronic disseminated intravascular coagulation 
(Schelling et al., 1986; Ramsey et al., 1996; Cury et al., 
2002), acquired von Willebrand’s disease (Whitley et al., 
2005) and immune-mediated thrombocytopenia (Gould and 
McInnes, 1999).  
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Thrombocytopenia has been reported in association with 
Angiostrongylus vasorum infection in a number of canine 
cases (Schelling et al., 1986; Patteson et al., 1993; 
Ramsey et al., 1996; Gould and McInnes, 1999; Brennan 
et al., 2004). In general the thrombocytopenia reported 
in these cases has been mild to moderate; none of the 
cases in the Chapman series presented with severe 
thrombocytopenia (Chapman et al., 2004). In a series of 
experimentally infected dogs (Cury et al., 2002) the mean 
platelet count in infected dogs was significantly lower 
than in the control dogs for approximately six months post 
infection, with the lowest mean thrombocyte count being 
about 100 x109/L post infection. In one previous case, 
the thrombocytopenia was demonstrated to be immune-
mediated (Gould and McInnes, 1999). On post mortem 
examination, this dog was additionally confirmed to have 
myocarditis, thrombosing arteritis, pneumonia and chronic 
membranoproliferative glomerulonephritis (Gould and 
McInnes, 1999).
Dogs with angiostrongylosis and resultant bleeding 
diatheses were evaluated as part of two recent case series 
(Brennan et al., 2004; Chapman et al., 2004), yielding 
very variable causes for the haemorrhage. Collectively 
these studies examined ten such dogs; one dog was 
mildly thrombocytopenic, two had mild thrombocytopenia 
and prolonged coagulation times, six had prolonged 
coagulation times alone and one had no demonstrable 
abnormality in haemostatic function. Hence, further 
investigations are required in order to fully characterize the 
mechanisms involved in the bleeding tendency infected 
dogs often show. In general, although disorders of both 
primary and secondary haemostasis have been reported 
to occur with Angiostrongylus infection (Schelling et al., 
1986; Ramsey et al., 1996; Cury et al., 2002; Brennan 
et al., 2004; Chapman et al., 2004; Whitley et al., 2005), 
thrombocytopenia as the primary cause is uncommon 
(Chapman et al., 2004).
The current case is the first reported case in which 
immune-mediated thrombocytopenia was observed 
in association with Angiostrongylus vasorum infection 
and successfully treated. It has been reported that 
approximately 40% of primary IMTP cases show a 
recurrence of clinical signs (Lewis and Meyers, 1996).  It 
would be expected that if this current case showed IMTP 
secondary to Angiostrongylus vasorum infection, there 
would be no recurrence of the signs following treatment 
of the lungworm infection. This dog was weaned off 
corticosteroids within five weeks and has since shown no 
recurrence of signs in seventeen months.  Hence, there 
is some circumstantial evidence that the Angiostrongylus 
vasorum infection may be linked to the IMTP; however, it 
cannot be confirmed.
CoNClUsIoNs
This is the first case report to describe the successful 
treatment of immune-mediated thrombocytopenia 
associated with Angiostrongylus vasorum infection.  IMTP in 
association with A. vasorum infection has been described 
previously (Gould and McInnes, 1999); however, the 
previous case was diagnosed post mortem. Both cases 
highlight the requirement to evaluate IMTP cases for an 
underlying cause and the potential for A. vasorum infection 
to trigger immune-mediated platelet destruction. The 
mechanism by which this destruction is triggered in the 
disease, whether it represents immune-complex deposition 
on platelets or the direct generation of anti-platelet 
antibodies, requires further evaluation.
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